Sanofi (SNY)

NYSE - NYSE Real Time Price. Currency in USD
38.35-0.22 (-0.57%)
At close: 4:02 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close38.57
Bid38.37 x 1500
Ask38.38 x 1600
Day's Range38.28 - 38.54
52wk Range37.41 - 51.88
1y Target EstN/A
Market Cap98.71B
P/E Ratio (ttm)21.39
Avg Vol (3m)2,454,938
Dividend & Yield1.66 (4.34%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters3 days ago

    Hard to swallow: emerging markets get tougher for drugmakers

    Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building. A few years ago, the developing world was seen as a savior as patent after patent expired across the United States and Europe, but emerging market sales growth at the top drug firms slowed to less than two percent in the latest quarter. Forecasts from independent experts IMS Health now suggest the United States will account for 55 percent of sales growth between 2016 and 2020, with emerging markets only contributing 30 percent.

  • Buffett Stock Wells Fargo Falls Close to 52-Week Low Post Scandal
    GuruFocus.com3 days ago

    Buffett Stock Wells Fargo Falls Close to 52-Week Low Post Scandal

    Unlike most Buffett stocks at lows, Wells' attractiveness remains unclear

  • TheStreet.com3 days ago

    New Setback for Sanofi's Lantus Increases Need for M&A

    UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.